What are the Historical Developments and Current Growth Metrics of the Sacral Nerve Stimulation Devices Market?
The sacral nerve stimulation devices market has seen considerable growth due to a variety of factors.
• The sacral nerve stimulation devices market has expanded significantly in recent years. It will increase from $1.33 billion in 2024 to $1.49 billion in 2025 at a CAGR of 11.9%.
This growth is linked to the increasing prevalence of urinary and fecal incontinence, advancements in neuromodulation technology, greater awareness of non-surgical treatment options, favorable reimbursement policies, the aging population, higher rates of neurological disorders, and increased healthcare spending.
What Does Future Hold for The Sacral Nerve Stimulation Devices Market By 2029?
The sacral nerve stimulation devices market is expected to maintain its strong growth trajectory in upcoming years.
• The sacral nerve stimulation devices market is expected to grow rapidly, reaching $2.31 billion by 2029 at a CAGR of 11.6%.
This growth is due to better reimbursement policies, greater acceptance of neuromodulation therapies, preference for non-invasive treatments, and increased exploration of sacral nerve stimulation devices. Trends include miniaturization, development of external stimulation devices, and improved patient education.
What Are The Primary Growth Drivers In The Sacral Nerve Stimulation Devices Market?
The escalating number of urological disorders is predicted to fuel the expansion of the sacral nerve stimulation devices market. These disorders typically involve conditions impacting the urinary tract, kidneys, bladder and prostate, with duration ranging from acute to chronic. The origins of urological disorders are diverse, impacting both the urinary tract and reproductive organs. Additionally, lifestyle choices such as unhealthy eating habits, insufficient hydration, and sedentary behavior can lead to the formation of kidney stones, a condition causing immense discomfort in the urinary tract. Sacral nerve stimulation devices offer a minimally invasive solution that can effectively alleviate urological disorders like urinary and fecal incontinence. For example, in April 2024, the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based healthcare organization, reported an average annual diagnosis of urinary incontinence in 651,446 individuals aged 65 and over (212,875 men and 438,572 women). Hence, the rising occurrence of urological disorders is anticipated to stimulate the growth of the sacral nerve stimulation devices market.
What Is The Segmentation Of The Global Sacral Nerve Stimulation Devices Market?
The sacral nerve stimulation devices market covered in this report is segmented –
1) By Type: Electrical Muscle Stimulation, Transcutaneous Electrical Nerve Stimulation
2) By Product: External Sacral Nerve Stimulation (SNS) Devices, Implantable Sacral Nerve Stimulation (SNS) Devices
3) By Age: Pediatrics, Adults, Geriatrics
4) By Application: Urinary Incontinence, Fecal Incontinence, Other Applications
5) By End User: Hospital, Ambulatory Surgical Centers, Specialty Clinics
Subsegments:
1) By Electrical Muscle Stimulation: Surface Electrical Muscle Stimulation, Implantable Electrical Muscle Stimulation
2) By Transcutaneous Electrical Nerve Stimulation: Conventional TENS, Burst Mode TENS, Modulated TENS
Pre-Book The Sacral Nerve Stimulation Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Sacral Nerve Stimulation Devices Market?
Leading corporations in the sacral nerve stimulation devices market are pioneering innovative products like next-generation sacral neuromodulation devices. These new tools are designed to enhance patient results, increase device effectiveness, and minimize unwanted side effects. Next-generation sacral neuromodulation devices grant improved control and effectiveness in stimulating sacral nerves. For example, in February 2022, Medtronic plc, a medical device company based in Ireland, unveiled the InterStim X. This next-generation device is specifically designed for sacral neuromodulation therapy used to manage conditions like overactive bladder (OAB), chronic fecal incontinence, and non-obstructive urinary retention. It provides long term personalized treatment without needing to be recharged. The InterStim X does not require recharging, providing patients with ten or more years of therapy, improving convenience and patient compliance.
Who Are the Key Players In The Sacral Nerve Stimulation Devices Market?
Major companies operating in the sacral nerve stimulation devices market are:
• Abbott
• Medtronic plc
• Boston Scientific Corporation
• Livanova
• Axonics Modulation Technologies
• Laborie Medical Technologies
• Beijing PINS Medical Co. Ltd.
• Nevro Corp.
• Cala Health
• Micro Systems Technologies
• Neuspera Medical
• EndoStim Inc.
• InCube Labs
• Soterix Medical
• Synapse Biomedical Inc
• Soin Neuroscience
• Nuvectra Corporation
• StimGuard LLC
• Medzell
• General Stim Inc.
What Are The Regional Insights Into The Sacral Nerve Stimulation Devices Market?
North America was the largest region in the sacral nerve stimulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
